Evidence map›Paper›PMID 35101263›Full record

ArticleVaccine2022

Measles susceptibility in maternal-infant dyads-Bamako, Mali.

Meredith G Dixon, Milagritos D Tapia, Kathleen Wannemuehler, Richard Luce, Mark Papania, Samba Sow, Myron M Levine, Marcela F Pasetti

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Surveillance and agnostic capture sequencing of samples from individuals with rash-associated illness in Mali indicates regional transmission of measles virus from West and Central Africa.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Meredith G DixonGlobal Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: mgdixon@cdc.gov.
Milagritos D TapiaCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
Kathleen WannemuehlerGlobal Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Department of Biostatistics & Medical Informatics, University of Wisconsin - Madison, WI, USA.
Richard LuceExpanded Program on Immunization, WHO Regional Office for Africa, Inter-Country Support Team for West Africa, Ouagadougou, Burkina Faso.
Mark PapaniaGlobal Immunization Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Samba SowCenter for Vaccine Development, Ministry of Health, Bamako, Mali.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
Marcela F PasettiCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mpasetti@som.umaryland.edu.
University of Maryland, Baltimore · USCenters for Disease Control and Prevention · USCentre Pour le Développement des Vaccins-Mali · MLNational Center for Immunization and Respiratory Diseases · USUnion Economique et Monétaire Ouest Africaine · BF

Funding

World Health Organization 001
6 · The paper itself

Abstract

Measles is endemic in Africa; measles mortality is highest among infants. Infant measles antibody titer at birth is related to maternal immune status. Older mothers are likelier to have had measles infection, which provides higher antibody titers than vaccine-induced immunity. We investigated the relationship between maternal age and measles susceptibility in mother-infant pairs in Mali through six months of infancy. We measured serum measles antibodies in 340 mother-infant pairs by plaque reduction neutralization test (PRNT) and calculated the proportion of mothers with protective titers (>120 mIU/mL) at delivery and the proportion of infants with protective titers at birth, and at three and six months of age. We explored associations between maternal age and measles antibodies in mothers and infants at the timepoints noted. Ten percent of Malian newborns were susceptible to measles; by six months nearly all were. Maternal and infant antibody titers were highly correlated. At delivery, 11% of mothers and 10% of newborns were susceptible to measles. By three and six months, infant susceptibility increased to 72% and 98%, respectively. Infants born to younger mothers were most susceptible at birth and three months. Time to susceptibility was 6.6 weeks in infants born to mothers with measles titer >120-<430 mIU/mL versus 15.4 weeks when mothers had titers ≥430 mIU/mL. Maternal and newborn seroprotective status were positively correlated. Improved strategies are needed to protect susceptible infants from measles infection and death. Increasing measles immunization coverage in vaccine eligible populations, including nonimmune reproductive-aged women and older children should be considered.

Indexed as

MeaslesMeasles VaccineAdolescentAdultAntibodies, ViralChildFemaleHumansImmunity, Maternally-AcquiredInfantInfant, NewbornMaliMeasles virusAntibodies, ViralMeasles VaccineMaternal antibodiesMeaslesMeasles immunizationMeasles plaque reduction neutralizationMother-infant

Identifiers

PMID35101263
PMCPMC8861573
OpenAlexW4210803500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.